Fifth Third Bancorp
CRSP icon

Fifth Third Bancorp’s CRISPR Therapeutics CRSP Stock Holding History

Fifth Third Bancorp’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15
Closed -$730 – 2689
2025
Q2 		$730 Sell
15
-5
-25% -$193 ﹤0.01% 2462
2025
Q1 		$681 Buy
+20
New +$848 ﹤0.01% 2428
2024
Q4 		– Sell
-250
Closed -$11.7K – 2533
2024
Q3 		$11.7K Hold
250
– – ﹤0.01% 1942
2024
Q2 		$13.5K Hold
250
– – ﹤0.01% 1839
2024
Q1 		$17K Sell
250
-125
-33% -$8.95K ﹤0.01% 1699
2023
Q4 		$23.5K Hold
375
– – ﹤0.01% 1721
2023
Q3 		$17K Sell
375
-350
-48% -$18.1K ﹤0.01% 1795
2023
Q2 		$40.7K Hold
725
– – ﹤0.01% 1450
2023
Q1 		$32.8K Hold
725
– – ﹤0.01% 1619
2022
Q4 		$29.5K Hold
725
– – ﹤0.01% 1560
2022
Q3 		$47K Hold
725
– – ﹤0.01% 1335
2022
Q2 		$44K Buy
725
+125
+21% +$7.35K ﹤0.01% 1409
2022
Q1 		$38K Sell
600
-1,050
-64% -$65.9K ﹤0.01% 1560
2021
Q4 		$125K Buy
1,650
+500
+43% +$43.7K ﹤0.01% 1164
2021
Q3 		$129K Buy
1,150
+450
+64% +$56.5K ﹤0.01% 1103
2021
Q2 		$113K Hold
700
– – ﹤0.01% 1151
2021
Q1 		$85K Hold
700
– – ﹤0.01% 1205
2020
Q4 		$107K Hold
700
– – ﹤0.01% 1132
2020
Q3 		$59K Hold
700
– – ﹤0.01% 1276
2020
Q2 		$51K Buy
700
+250
+56% +$14.6K ﹤0.01% 1299
2020
Q1 		$19K Buy
450
+350
+350% +$18.1K ﹤0.01% 1539
2019
Q4 		$6K Hold
100
– – ﹤0.01% 1925
2019
Q3 		$4K Hold
100
– – ﹤0.01% 1951
2019
Q2 		$5K Hold
100
– – ﹤0.01% 1989
2019
Q1 		$4K Hold
100
– – ﹤0.01% 1960
2018
Q4 		$3K Hold
100
– – ﹤0.01% 2047
2018
Q3 		$4K Buy
100
+20
+25% +$1.05K ﹤0.01% 2011
2018
Q2 		$5K Buy
+80
New +$4.56K ﹤0.01% 2037

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Fifth Third Bancorp's CRSP Position: Q3 2025 in Review

Fifth Third Bancorp sold out of CRISPR Therapeutics (CRSP) in Q3 2025, closing a stake of 15 shares — an estimated $730 sold.

Fifth Third Bancorp first reported a position in CRSP in Q2 2018 and held it in 28 quarters. The position peaked at $129K in Q3 2021. 440 funds tracked by Wall St. Rank hold CRSP as of Q3 2025.

  • Fifth Third Bancorp reported no remaining CRISPR Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 15 CRISPR Therapeutics shares in Q3 2025, an estimated $730.
  • Fifth Third Bancorp first reported a position in CRISPR Therapeutics in Q2 2018 and held it in 28 quarters.
  • Fifth Third Bancorp's CRISPR Therapeutics position peaked at $129K in Q3 2021.
  • 440 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2025.

Based on Fifth Third Bancorp's 13F filing for Q3 2025, filed 7 Nov 2025.